Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

US Bioservices now dispenses TAVALISSE

June 18, 2018

The U.S. Food and Drug Administration has recently approved TAVALISSE (fostamatinib) for the treatment of chronic/persistent immune thrombocytopenic purpura (ITP).